Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.
about
High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticityObesity Reduces Cognitive and Motor Functions across the LifespanIntranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the artTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseAberrant insulin signaling in Alzheimer's disease: current knowledgeOmega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's DiseaseBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseChanges in brainstem auditory evoked potentials among North Indian females with Type 2 diabetes mellitus.Growth hormone secretagogue receptor (GHS-R1a) knockout mice exhibit improved spatial memory and deficits in contextual memoryBrainstem auditory evoked potential abnormalities in type 2 diabetes mellitus.Ceramide-mediated insulin resistance and impairment of cognitive-motor functionsCCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5.si-RNA inhibition of brain insulin or insulin-like growth factor receptors causes developmental cerebellar abnormalities: relevance to fetal alcohol spectrum disorder.CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseaseThe central clock neurons regulate lipid storage in Drosophila.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesType 3 diabetes is sporadic Alzheimer׳s disease: mini-review.Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.Brain metabolic dysfunction at the core of Alzheimer's disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedDysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's diseaseTime for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine.Differential Contributions of Alcohol and the Nicotine-Derived Nitrosamine Ketone (NNK) to Insulin and Insulin-Like Growth Factor Resistance in the Adolescent Rat Brain.Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathology in the Adolescent Rat Brain.Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease.Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?The adverse impact of type 2 diabetes on brain volume in heart failure.Liver and diabetes. A vicious circle.Neuroinflammatory and autonomic mechanisms in diabetes and hypertension.Relationships between diabetes and cognitive impairmentExperimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficitsLong-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.Neuroinflammation and neurodegeneration in overnutrition-induced diseases.Insulin dysfunction and Tau pathology.Minireview: Food for thought: regulation of synaptic function by metabolic hormones.Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline.The role of melatonin in the onset and progression of type 3 diabetes.Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
P2860
Q21131756-01A28CEA-1C2D-40F9-AAF6-142C4B35CB94Q26765753-6D5384A9-D2D2-4A1B-B7E8-ED94406F05E3Q26830845-FBE407FB-942F-4F10-A3C8-D37AF85F6F0FQ27021700-90B873CF-6468-41B3-BF61-51CEB6BEC8B4Q27024222-7AD394FF-E70D-4584-B0A2-C17C9CC9615FQ28080464-5D746A88-C4C7-4FAF-AE9D-E9106ABAE476Q28259585-7234C040-C3E6-4D8E-9EF9-8D45F9EF0C89Q30445270-5485C4DB-C7A2-4084-8999-0FDF27115B2FQ30453485-D9F8C086-36B4-4655-9B6B-938D66EAF66DQ30458735-2C56503E-F0DB-4334-B503-06DA40C1BFEDQ30478907-94DC98A2-BB0F-4B13-BF6F-24F1ABDA76C8Q30830123-B1104D29-4B60-4847-8896-6B1613019DE5Q30968670-9D7EE120-A7A2-4D6B-BC72-DDB6B305E229Q33896118-47F51E3A-BD72-4A46-A73B-BB748A1A3052Q33916864-4D10214E-3739-4D8C-A0A7-12ED74B45A0DQ34288447-848CF63F-31AE-4942-B710-3D3EEEF64211Q34432135-17140799-9E87-4E5F-A926-F4BFD760D056Q35976627-45032687-6D4E-4516-A27A-4F911D1424CBQ35997881-DDF22508-938F-42B9-99A7-C897FBD7B668Q35997884-90322A00-9BAD-4779-B482-09F514DDD9E6Q36036789-80754932-AA6C-469B-A57F-8056C2E7E21BQ36117556-46BEA196-DD69-4A5E-8D86-33A1CE194F74Q36170557-F78BE415-DF46-4AB1-B155-50690BE31478Q36170564-19D457EE-C8E1-4141-B853-3686259B3575Q36355644-F8A26E53-0225-49F3-A50B-8F2231B05F0EQ36768801-ABEA1674-C981-4CB1-82C0-B4C6773599ACQ36786697-0AE1B271-8BB7-4BAA-A8C3-FD30DF31AC73Q37070333-C68A5DCC-9DDE-4B53-B0F6-FB429C964FDCQ37139426-96C3C1D9-7577-4D18-B237-5B522804BCEFQ37162219-17FFFE06-511F-4EE3-99D5-8AAA1EF75662Q37615991-963180FE-C8FF-46DB-8E18-AC1810EC1211Q37739590-F77EB128-4275-4C5E-A8DE-E51B5FD6F124Q38069685-A3D8F4B3-F05F-43CE-8C2F-B12521BA9E74Q38191590-D937452B-6A06-498D-8DB4-EB1F962D65C4Q38282299-4646B2CF-CF1C-4AA7-97AA-28F250D807FCQ38938961-B669C7D9-8C76-4E77-B3A6-9CA071D202B6Q39042377-26A41E1C-4CC0-442B-A4AD-B152E96D4A04Q40203146-B20515A3-B414-4864-BC02-128BA347DFBAQ41206619-C3EFF505-AE46-49DD-A8A9-F48467AC46F3Q41566472-8FAEFA06-F0FD-4A39-BF34-A289B2884985
P2860
Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin resistance and neurode ...... non-alcoholic steatohepatitis.
@en
Insulin resistance and neurode ...... non-alcoholic steatohepatitis.
@nl
type
label
Insulin resistance and neurode ...... non-alcoholic steatohepatitis.
@en
Insulin resistance and neurode ...... non-alcoholic steatohepatitis.
@nl
prefLabel
Insulin resistance and neurode ...... non-alcoholic steatohepatitis.
@en
Insulin resistance and neurode ...... non-alcoholic steatohepatitis.
@nl
P2093
P2860
P921
P1476
Insulin resistance and neurode ...... non-alcoholic steatohepatitis
@en
P2093
Jack R Wands
Lisa Longato
Suzanne M de la Monte
P2860
P304
P577
2009-10-01T00:00:00Z